TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
TFA Therapeutics's net income for the twelve months ending Dec 31, 2023 was $751.61K. For fiscal 2025 it was -$154.82K. The highest annual figure on record is $751.61K in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$154.82K | – |
| FY2024 | Dec 31, 2024 | -$226.26K | -130.1% |
| FY2023 | Dec 31, 2023 | $751.61K | – |
| FY2022 | Dec 31, 2022 | -$720.09K | – |
| FY2021 | Dec 31, 2021 | -$491.01K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $901.17K | – |
| Q4 FY2022 | Dec 31, 2022 | -$77.05K | – |
See a number that looks wrong?